Northern Trust’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
234,992
+8,691
+4% +$99.6K ﹤0.01% 2751
2025
Q4
$2.33M Sell
226,301
-27,306
-11% -$230K ﹤0.01% 2909
2025
Q3
$1.47M Sell
253,607
-46,714
-16% -$273K ﹤0.01% 3199
2025
Q2
$2.02M Sell
300,321
-9,866
-3% -$79.4K ﹤0.01% 2982
2025
Q1
$2.8M Sell
310,187
-7,990
-3% -$99.6K ﹤0.01% 2742
2024
Q4
$5.5M Buy
318,177
+70,497
+28% +$1.28M ﹤0.01% 2455
2024
Q3
$3.96M Buy
247,680
+57,371
+30% +$904K ﹤0.01% 2614
2024
Q2
$2.71M Sell
190,309
-9,033
-5% -$128K ﹤0.01% 2742
2024
Q1
$2.82M Sell
199,342
-1,346
-0.7% -$19K ﹤0.01% 2786
2023
Q4
$3.03M Sell
200,688
-4,373
-2% -$64.8K ﹤0.01% 2771
2023
Q3
$3.24M Buy
205,061
+10,967
+6% +$173K ﹤0.01% 2678
2023
Q2
$2.94M Buy
194,094
+160,701
+481% +$2.21M ﹤0.01% 2791
2023
Q1
$484K Sell
33,393
-967
-3% -$12.9K ﹤0.01% 3479
2022
Q4
$465K Buy
34,360
+4,363
+15% +$76.5K ﹤0.01% 3532
2022
Q3
$473K Buy
29,997
+13,669
+84% +$174K ﹤0.01% 3538
2022
Q2
$199K Sell
16,328
-73,930
-82% -$561K ﹤0.01% 3930
2022
Q1
$847K Buy
90,258
+10,775
+14% +$116K ﹤0.01% 3505
2021
Q4
$1.36M Buy
+79,483
New +$1.93M ﹤0.01% 3413

Other funds holding TRDA